Arttamangkul Seksiri, Quillinan Nidia, Low Malcolm J, von Zastrow Mark, Pintar John, Williams John T
Vollum Institute, L474, Department of Behavioral Neuroscience, Oregon Health Sciences University, 3181 W Sam Jackson Park Dr., Portland, OR 97239, USA.
Mol Pharmacol. 2008 Oct;74(4):972-9. doi: 10.1124/mol.108.048512. Epub 2008 Jul 8.
The activation of G protein-coupled receptors results in a cascade of events that include acute signaling, desensitization, and internalization, and it is thought that not all agonists affect each process to the same extent. The early steps in opioid receptor signaling, including desensitization, have been characterized electrophysiologically using brain slice preparations, whereas most previous studies of opioid receptor trafficking have been conducted in heterologous cell models. This study used transgenic mice that express an epitope-tagged (FLAG) micro-opioid receptor (FLAGMOR) targeted to catecholamine neurons by regulatory elements from the tyrosine hydroxylase gene. Brain slices from these mice were used to study tagged MOR receptors in neurons of the locus ceruleus. Activation of the FLAGMOR with [Met5]enkephalin (ME) produced a hyperpolarization that desensitized acutely to the same extent as native MOR in slices from wild-type mice. A series of opioid agonists were then used to study desensitization and receptor trafficking in brain slices, which was monitored with a monoclonal antibody against the FLAG epitope (M1) conjugated to Alexa 594. Three patterns of receptor trafficking and desensitization were observed: 1) ME, etorphine, and methadone resulted in both receptor desensitization and internalization; 2) morphine and oxymorphone caused significant desensitization without evidence for internalization; and 3) oxycodone was ineffective in both processes. These results show that two distinct forms of signaling were differentially engaged depending on the agonist used to activate the receptor, and they support the hypothesis that ligand-specific regulation of opioid receptors occurs in neurons maintained in brain slices from adult animals.
G蛋白偶联受体的激活会引发一系列事件,包括急性信号传导、脱敏和内化,并且人们认为并非所有激动剂对每个过程的影响程度都相同。阿片受体信号传导的早期步骤,包括脱敏,已通过脑片制备进行了电生理学表征,而之前大多数关于阿片受体转运的研究都是在异源细胞模型中进行的。本研究使用了转基因小鼠,这些小鼠通过酪氨酸羟化酶基因的调控元件表达靶向儿茶酚胺神经元的表位标签(FLAG)微阿片受体(FLAGMOR)。来自这些小鼠的脑片用于研究蓝斑核神经元中的标记MOR受体。用[Met5]脑啡肽(ME)激活FLAGMOR会产生超极化,其急性脱敏程度与野生型小鼠脑片中的天然MOR相同。然后使用一系列阿片激动剂来研究脑片中的脱敏和受体转运,并用与Alexa 594偶联的抗FLAG表位单克隆抗体(M1)进行监测。观察到三种受体转运和脱敏模式:1)ME、埃托啡和美沙酮导致受体脱敏和内化;2)吗啡和羟吗啡酮引起显著脱敏,但无内化证据;3)羟考酮在这两个过程中均无效。这些结果表明,根据用于激活受体的激动剂不同,两种不同形式的信号传导被不同程度地激活,并且支持这样的假设,即阿片受体的配体特异性调节发生在成年动物脑片培养的神经元中。